No products in the cart.
Brand
Buy Kryxana ‘Kisqali’ (ribociclib) – International Cost
$986.00
Kryxana® (also known as Kisqali®) is used in combination with other drugs for the treatment of advanced or metastatic breast cancer whose cells are hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-).
Package Size : 21 Tablets
Active Ingredient : Ribociclib 200 MG
Manufactured by Novartis AG®
Product of Singapore
No prescription? Do you have an old Kisqali pack with your info on it? Click here for help
Delivery of this medication takes 3 to 5 days by DHL Express
In stock
- Kryxana® / Kisqali® works by blocking the activity of two enzymes (CDK4 and CDK6) that are important for cancer cells growth and division
- Liver function tests (LFTs) should be performed before starting treatment with Kryxana® / Kisqali® and monitored throughout
- Neutropenia (low levels of a type of white blood cells) was the most frequently reported adverse reaction in Kisqali®’s clinical trials
- Patients should be monitored for pulmonary symptoms as severe, life-threatening interstitial lung disease and/or pneumonitis can occur in patients treated with Kryxana® / Kisqali®
- Severe cutaneous reactions have occurred during treatment, discontinue Kryxana® / Kisqali® use if life-threatening reactions are suspected
- Kryxana® / Kisqali® can cause harm to unborn babies, patients should not get pregnant or breast feed while taking it
Please refer to the manufacturer’s website to learn all the information needed to use this medicine safely and effectively
Only logged in customers who have purchased this product may leave a review.
Related products
Brand
$648.00 – $698.00
Brand
$468.00
Brand
$994.00
Cardiovascular
$95.00 – $99.00
Brand
$988.00 – $1,565.00
Brand
$648.00
Brand
$379.00 – $794.00
Brand
$54.00
Reviews
There are no reviews yet.